Cooper Companies (NASDAQ:COO – Get Free Report) issued its quarterly earnings results on Thursday. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04, Zacks reports. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the business posted $0.87 earnings per share. The business’s revenue was up 9.8% compared to the same quarter last year. Cooper Companies updated its FY25 guidance to $3.92-$4.02 EPS.
Cooper Companies Trading Down 1.7 %
Shares of NASDAQ:COO traded down $1.75 during trading on Thursday, reaching $103.23. The stock had a trading volume of 1,842,913 shares, compared to its average volume of 1,140,510. The business has a fifty day moving average price of $104.84 and a 200-day moving average price of $98.74. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The stock has a market cap of $20.56 billion, a P/E ratio of 57.81, a PEG ratio of 2.24 and a beta of 0.97. Cooper Companies has a fifty-two week low of $82.69 and a fifty-two week high of $112.38.
Insider Activity
In other news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Report on COO
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Recommended Stories
- Five stocks we like better than Cooper Companies
- How to Invest in Blue Chip Stocks
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Canadian Penny Stocks: Can They Make You Rich?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.